局所進行性または転移性乳がんに対するPARP阻害薬 https://t.co/cKMnLEasHZ

RT @CochraneLibrary: PARP inhibitors for locally advanced or metastatic #breastcancer https://t.co/h4wqApCsgo New @CochraneBCancer systemat…

RT @TVVde: PARP-Inhibitoren sind ein großartiges Beispiel dafür, wie aus der Grundlagenforschung eine ganz neue Klasse von Wirkstoffen ents…

PARP-Inhibitoren sind ein großartiges Beispiel dafür, wie aus der Grundlagenforschung eine ganz neue Klasse von Wirkstoffen entstehen konnte, die heute Tausenden Krebspatientinnen das Leben verlängern. Entscheidende Erkenntnisse wurden dabei mit Tierversuc

RT @Cochrane_DE: Wirken PARP-Inhibitoren bei bestimmten Formen von lokal fortgeschrittenem oder metastasiertem #Brustkrebs? Das untersucht…

Wirken PARP-Inhibitoren bei bestimmten Formen von lokal fortgeschrittenem oder metastasiertem #Brustkrebs? Das untersucht ein #CochraneReview von @CochraneBCancer. Fazit: PARP-Inhibitoren können eine sinnvolle Ergänzung der Therapiestrategie sein. https://

RT @WileyOnc_Hem: Read this new @CochraneLibrary @CochraneBCancer systematic review on PARP inhibitors for locally advanced or metastatic #…

Read this new @CochraneLibrary @CochraneBCancer systematic review on PARP inhibitors for locally advanced or metastatic #breastcancer. It looks at the evidence of 5 trials involving 1,474 participants: https://t.co/1xZFcUHS31 https://t.co/w6scOXT2TK

Read this new @CochraneLibrary @CochraneBCancer systematic review on PARP inhibitors for locally advanced or metastatic #breastcancer. It looks at the evidence of 5 trials involving 1474 participants. >>> https://t.co/COmYeDIGJM https://t.co/6D2

RT @Wiley_Nursing: Read this new @CochraneLibrary @CochraneBCancer systematic review on PARP inhibitors for locally advanced or metastatic…

Read this new @CochraneLibrary @CochraneBCancer systematic review on PARP inhibitors for locally advanced or metastatic #breastcancer which looks at the evidence of 5 trials involving 1474 participants https://t.co/QRA2gpBFt7 https://t.co/8TxcEKrxmf

PARP inhibitors for locally advanced or metastatic #breastcancer https://t.co/ewkruRoQ9G New @CochraneBCancer systematic review looks at the evidence of 5 trials involving 1474 participants. https://t.co/Ptl5LvRIU8

PARP inhibitors for locally advanced or metastatic breast cancer https://t.co/LaVFSL3k1Q

RT @FilippoMontemu1: PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer https://t.co/4W1XIGqsrL…

RT @CochraneUK: PARP inhibitors for locally advanced or metastatic #breastcancer https://t.co/hldIYJSfBm New @CochraneBCancer systematic re…

PARP inhibitors for locally advanced or metastatic #breastcancer https://t.co/hldIYJSfBm New @CochraneBCancer systematic review looks at the evidence of 5 trials involving 1474 participants. https://t.co/Nj4s3wZLI1

RT @CochraneLibrary: PARP inhibitors for locally advanced or metastatic #breastcancer https://t.co/h4wqApCsgo New @CochraneBCancer systemat…

RT @CochraneLibrary: PARP inhibitors for locally advanced or metastatic #breastcancer https://t.co/h4wqApCsgo New @CochraneBCancer systemat…

RT @CochraneLibrary: PARP inhibitors for locally advanced or metastatic #breastcancer https://t.co/h4wqApCsgo New @CochraneBCancer systemat…

RT @CochraneLibrary: PARP inhibitors for locally advanced or metastatic #breastcancer https://t.co/h4wqApCsgo New @CochraneBCancer systemat…

PARP inhibitors for locally advanced or metastatic #breastcancer https://t.co/h4wqApCsgo New @CochraneBCancer systematic review looks at the evidence of 5 trials involving 1474 participants.

PARP inhibitors for locally advanced or metastatic breast cancer https://t.co/Ws3nVFuqla

PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer https://t.co/4W1XIGqsrL if there were any lingering doubt..🙂

RT @MKhasraw: Great work @DrAmeliaTaylor1 @MarkRobsonMD

Great work @DrAmeliaTaylor1 @MarkRobsonMD

Metanalysis of RCTs involving PARPi in locally advanced or metastatic HER2‐negative, BRCA germline mutated breast cancer, demonstrates an improvement in progression‐free survival, and likely improved overall survival and tumor response rates https://t.co

#PARP (Poly ADP-Ribose Polymerase) #inhibitors for locally advanced or #metastatic #breast #cancer (followed by Marc #Lacroix, #Wallonia) https://t.co/Wv7qExA9z9 #oncology